SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001214659-15-003965
Filing Date
2015-05-14
Accepted
2015-05-14 17:30:00
Documents
2
Group Members
BIOVISION LIFE SCIENCE FUND NO.1SBI BB MOBILE INVESTMENT LPSSBI BIO LIFE SCIENCE INVESTMENT LPSSBI CAPITAL MANAGEMENT CO. LTD.SBI INCUBATION CO. LTD.SBI INVESTMENT CO. LTD.SBI PHOENIX NO. 1 INVESTMENT LPSSBI TRANSSCIENCE CO. LTD.TRANS-SCIENCE NO. 2A INVES

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 7 j514152sc13da7.htm SC 13D/A 270841
2 EXHIBIT 7.4 ex7_4.htm EX-7.4 26652
  Complete submission text file 0001214659-15-003965.txt   299618
Mailing Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101
Business Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101 206-805-8300
ACUCELA INC. (Subject) CIK: 0001400482 (see all company filings)

IRS No.: 020592619 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88011 | Film No.: 15864190
SIC: 2834 Pharmaceutical Preparations

Mailing Address IZUMI GARDEN TOWER 19F, 1-6-1 ROPPONGI MINATO-KU TOKYO M0 106-6019
Business Address IZUMI GARDEN TOWER 19F, 1-6-1 ROPPONGI MINATO-KU TOKYO M0 106-6019 81-3-6229-0122
SBI Holdings, Inc. (Filed by) CIK: 0001446698 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC 13D/A